These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 39415300)
61. Elevated Serum Levels of Sclerostin are Associated with High Disease Activity and Functional Impairment in Patients with Axial Spondyloarthritis. Muntean L; Lungu A; Gheorghe SR; Valeanu M; Craciun AM; Felea I; Petcu A; Filipescu I; Simon SP; Rednic S Clin Lab; 2016; 62(4):589-97. PubMed ID: 27215077 [TBL] [Abstract][Full Text] [Related]
62. Correlation between clinical disease activity and sacroiliac magnetic resonance imaging detection in axial spondyloarthropathy. Inan O; Aytekin E; Pekin Dogan Y; Nahit Mutlu I; Aydemir K; Oz N; Sayiner Caglar N Arch Rheumatol; 2024 Mar; 39(1):115-122. PubMed ID: 38774700 [TBL] [Abstract][Full Text] [Related]
63. Comparing symptoms, treatment patterns, and quality of life of ankylosing spondylitis and non-radiographic axial spondyloarthritis patients in the USA: findings from a patient and rheumatologist Survey. Hunter T; Sandoval D; Booth N; Holdsworth E; Deodhar A Clin Rheumatol; 2021 Aug; 40(8):3161-3167. PubMed ID: 33611647 [TBL] [Abstract][Full Text] [Related]
64. The relationship between central sensitization and disease activity, quality of life, and sleep quality among patients with axial spondyloarthritis. Aykurt Karlıbel I; Kasapoğlu Aksoy M Ir J Med Sci; 2023 Feb; 192(1):481-489. PubMed ID: 35226249 [TBL] [Abstract][Full Text] [Related]
65. Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2. Navarro-Compán V; Ramiro S; Deodhar A; Mease PJ; Rudwaleit M; de la Loge C; Fleurinck C; Taieb V; Mørup MF; Massow U; Kay J; Magrey M RMD Open; 2024 Apr; 10(2):. PubMed ID: 38599650 [TBL] [Abstract][Full Text] [Related]
66. Association of obesity with inflammation, disease severity and cardiovascular risk factors among patients with ankylosing spondylitis. Chen CH; Chen HA; Liu CH; Liao HT; Chou CT; Chen CH Int J Rheum Dis; 2020 Aug; 23(9):1165-1174. PubMed ID: 32830454 [TBL] [Abstract][Full Text] [Related]
67. Sustained clinical response and safety of etanercept in patients with early axial spondyloarthritis: 10-year results of the ESTHER trial. Proft F; Weiß A; Torgutalp M; Protopopov M; Rodriguez VR; Haibel H; Behmer O; Sieper J; Poddubnyy D Ther Adv Musculoskelet Dis; 2021; 13():1759720X20987700. PubMed ID: 33796155 [TBL] [Abstract][Full Text] [Related]
68. Evaluation of spondylarthritis activity by patients and physicians: ASDAS, BASDAI, PASS, and flares in 200 patients. Godfrin-Valnet M; Prati C; Puyraveau M; Toussirot E; Letho-Gyselink H; Wendling D Joint Bone Spine; 2013 Jul; 80(4):393-8. PubMed ID: 23453478 [TBL] [Abstract][Full Text] [Related]
69. Platelet to albumin ratio is an independent indicator for disease activity in ankylosing spondylitis. Cui R; Wang YL; Tao YL; Tong Q; Chen Z; Dai SM Clin Rheumatol; 2023 Feb; 42(2):407-413. PubMed ID: 36414863 [TBL] [Abstract][Full Text] [Related]
70. Preliminary definitions of 'flare' in axial spondyloarthritis, based on pain, BASDAI and ASDAS-CRP: an ASAS initiative. Gossec L; Portier A; Landewé R; Etcheto A; Navarro-Compán V; Kroon F; van der Heijde D; Dougados M Ann Rheum Dis; 2016 Jun; 75(6):991-6. PubMed ID: 26847821 [TBL] [Abstract][Full Text] [Related]
71. Impact of daily physical therapy over 2 weeks on spinal mobility including objective electronic measurements and function in patients with axial spondyloarthritis. Kiefer D; Schneider L; Braun J; Kiltz U; Kolle N; Andreica I; Tsiami S; Buehring B; Sewerin P; Herbold S; Baraliakos X Ther Adv Musculoskelet Dis; 2024; 16():1759720X231224212. PubMed ID: 38404654 [TBL] [Abstract][Full Text] [Related]
72. Effect of certolizumab pegol over ninety-six weeks in patients with axial spondyloarthritis: results from a phase III randomized trial. Sieper J; Landewé R; Rudwaleit M; van der Heijde D; Dougados M; Mease PJ; Braun J; Deodhar A; Kivitz A; Walsh J; Hoepken B; Nurminen T; Maksymowych WP Arthritis Rheumatol; 2015 Mar; 67(3):668-77. PubMed ID: 25470228 [TBL] [Abstract][Full Text] [Related]
73. The validity and reliability of quality of life questionnaires in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and meta-analysis. He Q; Luo J; Chen J; Yang J; Yao C; Xu C; Tao Q Health Qual Life Outcomes; 2022 Jul; 20(1):116. PubMed ID: 35907948 [TBL] [Abstract][Full Text] [Related]
74. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi. Malaviya AN; Kalyani A; Rawat R; Gogia SB Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961 [TBL] [Abstract][Full Text] [Related]
75. Efficacy and safety of mind-body exercise for patients with axial spondyloarthritis: a systematic review and meta-analysis. Wang J; Li X; Yang F; Guo P; Ren C; Duan Z; Zhang Y J Orthop Surg Res; 2024 Sep; 19(1):586. PubMed ID: 39342350 [TBL] [Abstract][Full Text] [Related]
76. Reduced sleep quality is highly prevalent and associated with physical function and cardiorespiratory fitness in patients with axial spondyloarthritis: a cross-sectional study. Fongen C; Dagfinrud H; Bilberg A; Sveaas SH Scand J Rheumatol; 2024 Mar; 53(2):130-139. PubMed ID: 38095452 [TBL] [Abstract][Full Text] [Related]
77. Axial Spondyloarthritis Treatment Recommendations and Disease Activity Monitoring in Clinical Practice: Results of an Online Survey. Sinnappan S; Forte A; Ermann J J Rheumatol; 2024 May; 51(5):472-478. PubMed ID: 38224985 [TBL] [Abstract][Full Text] [Related]
78. The effects of physical exercise on axial spondyloarthritis - a systematic review. Pina Gonçalves N; Emília Santos M; Silvério-António M; Donato H; Pimentel-Santos FM; Cruz E ARP Rheumatol; 2023 Aug; ():. PubMed ID: 37728143 [TBL] [Abstract][Full Text] [Related]
79. Activity Limitations in Patients with Axial Spondyloarthritis: A Role for Fear of Movement and (Re)injury Beliefs. Swinnen TW; Vlaeyen JWS; Dankaerts W; Westhovens R; de Vlam K J Rheumatol; 2018 Mar; 45(3):357-366. PubMed ID: 29142031 [TBL] [Abstract][Full Text] [Related]
80. The ASAS-OMERACT core domain set for axial spondyloarthritis. Navarro-Compán V; Boel A; Boonen A; Mease P; Landewé R; Kiltz U; Dougados M; Baraliakos X; Bautista-Molano W; Carlier H; Chiowchanwisawakit P; Dagfinrud H; de Peyrecave N; El-Zorkany B; Fallon L; Gaffney K; Garrido-Cumbrera M; Gensler LS; Haroon N; Kwan YH; Machado PM; Maksymowych WP; Poddubnyy D; Protopopov M; Ramiro S; Shea B; Song IH; van Weely S; van der Heijde D Semin Arthritis Rheum; 2021 Dec; 51(6):1342-1349. PubMed ID: 34489113 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]